Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 15/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4883056 | 0.87 | KMT2A (0.52) | NPC1RAB9A | |
| SCHEMBL2955532 | 0.82 | CA12 (0.70) | EPHX2RECQLCA12CA1CA2 | |
| SCHEMBL4886950 | 0.80 | MMP13 (0.48) | EPHX2 | |
| Hydrochloric Acid SCHEMBL4603213 | 0.79 | EPHX2 (0.61) | EPHX2RECQLEPHX1NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL4880489 | 0.79 | EPHX2 (0.61) | EPHX2RECQLEPHX1NPC1RAB9A | |
| SCHEMBL1425366 | 0.75 | EPHX2 (0.71) | EPHX2RECQLEPHX1NPC1RAB9A | |
| SCHEMBL4889350 | 0.75 | EPHX2 (0.47) | EPHX2RECQLEPHX1NPC1RAB9A | |
| SCHEMBL1425023 | 0.75 | EPHX2 (0.74) | EPHX2RECQLEPHX1NPC1RAB9A | |
| SCHEMBL27745908 | 0.74 | RECQL (0.62) | EPHX2RECQLEPHX1NPC1RAB9A | |
| SCHEMBL2718126 | 0.74 | EPHX2 (0.73) | EPHX2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | KANG JAE-HOON | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | PDF, PEPD, DHPS | EPHX2 2553/4885RECQL 1998/4885CA12 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.